PubRank

C Aizawa

Author PubWeight™ 57.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods 1997 1.62
2 Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 1990 1.62
3 Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988 1.55
4 Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J Biol Chem 1996 1.43
5 A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol 1999 1.42
6 Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 1992 1.40
7 Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol 1992 1.38
8 Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J Immunol 1996 1.37
9 Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur J Immunol 1991 1.22
10 H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin. Immunology 1991 1.20
11 Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J Gen Virol 1998 1.19
12 Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984 1.18
13 Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. Vaccine 1989 1.13
14 Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J Gen Virol 1999 1.11
15 Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine 1992 1.10
16 Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J Immunol Methods 1995 1.06
17 Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. Vaccine 1989 1.05
18 Molecular cloning and complete nucleotide sequence of the genome of Japanese encephalitis virus Beijing-1 strain. Virus Genes 1988 1.02
19 Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 1998 1.01
20 Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine 1990 1.00
21 Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain. Vaccine 2001 0.99
22 Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit. Vaccine 1989 0.99
23 Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 1996 0.99
24 Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 1999 0.98
25 Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Vaccine 2000 0.97
26 Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine 1994 0.96
27 Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I. Arch Virol 1995 0.95
28 Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine. Vaccine 1999 0.93
29 C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1987 0.91
30 Cloning of the gene coding for Staphylococcus hyicus exfoliative toxin B and its expression in Escherichia coli. J Bacteriol 2000 0.91
31 New exfoliative toxin produced by a plasmid-carrying strain of Staphylococcus hyicus. Infect Immun 1999 0.90
32 Chromosomal and extrachromosomal synthesis of exfoliative toxin from Staphylococcus hyicus. J Bacteriol 2000 0.90
33 Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Vaccine 2001 0.90
34 Effect of dual-subtype vaccine against feline immunodeficiency virus infection. Vet Microbiol 1997 0.88
35 Antihypertensive effect of gamma-amino butyric acid enriched soy products in spontaneously hypertensive rats. Biofactors 2004 0.87
36 Effect of elevated ureteral pressure on renal medullary osmolal concentration in hydropenic rabbits. Am J Physiol 1971 0.87
37 Large-scale purification of Japanese encephalitis virus from infected mouse brain for preparation of vaccine. Appl Environ Microbiol 1980 0.87
38 Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin. Vaccine 1995 0.86
39 Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin. Vaccine 1997 0.86
40 IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. Vaccine 1998 0.85
41 Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccines combined with cholera toxin B subunit. Vaccine 1990 0.83
42 Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. J Allergy Clin Immunol 2000 0.82
43 New nuclear ribonucleic acid in cell cultures infected with polyoma virus. J Virol 1969 0.82
44 Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1998 0.82
45 Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effective adjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines. Vaccine 2001 0.82
46 Enhancement of DTH response by cholera toxin B subunit inoculated intranasally together with influenza HA vaccine. Microbiol Immunol 1990 0.81
47 C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q. J Immunol Methods 1984 0.80
48 Preparation of Japanese encephalitis virus nonstructural protein NS1 obtained from culture fluid of JEV-infected Vero cells. Arch Virol 1991 0.80
49 Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine. Vaccine 2001 0.79
50 Detection of feline immunodeficiency proviral DNA in peripheral blood lymphocytes by the polymerase chain reaction. Vet Microbiol 1992 0.79
51 Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice. Vaccine 1994 0.79
52 Immunostimulatory activity of 1-O-acylated muramyl dipeptides, with or without a 6-O-phosphoryl group, in aqueous form. Int J Immunopharmacol 1989 0.79
53 Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2. Acta Virol 1995 0.79
54 Permeable type I collagen membrane promotes glomerular epithelial cell growth in culture. Kidney Int 1993 0.79
55 Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration. Vaccine 1995 0.78
56 Effect of elevated venous pressure on medullary osmolar gradient in rabbit kidney. Am J Physiol 1970 0.78
57 Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid. Vaccine 2001 0.77
58 Depletion of the renal medullary osmotic gradient following hemorrhagic hypotension in hydropenic rabbits. Jpn Heart J 1969 0.76
59 Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides. Infect Immun 1989 0.75
60 [Echinococcus granulosus infecting lung and liver. Report of a case (author's transl)]. Kyobu Geka 1982 0.75
61 A new ultramicro analysis of protein by S.D.S. polyacrylamide gel electrophoresis. Jpn J Pharmacol 1974 0.75
62 Inhibition of replication of vesicular stomatitis virus in mouse embryonic cell culture infected with Japanese encephalitis virus. Kitasato Arch Exp Med 1973 0.75
63 Comparative study on neutralization tests in Japanese encephalitis. Kitasato Arch Exp Med 1966 0.75
64 Postocclusive reactive hyperemia in the rabbit kidney. Am J Physiol 1968 0.75
65 [Renal circulation dynamics, urine concentration and dilution ability]. Nihon Rinsho 1983 0.75
66 [Serological study of neutralizing (NT) antibody against Japanese encephalitis virus in non-affected district of Tokyo]. Kansenshogaku Zasshi 1987 0.75
67 Some biologic differences in Japanese encephalitis viruses. Kitasato Arch Exp Med 1972 0.75
68 Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis. Jpn J Med 1991 0.75
69 Postocclusive vascular responses in isolated perfused kidney of rabbits. Am J Physiol 1972 0.75
70 Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection. Vaccine 1997 0.75
71 Differences in haemagglutination activity and electrophoretic mobility of E protein between the parent SA14 and attenuated vaccine SA14-14-2 strains of Japanese encephalitis virus. Acta Virol 1995 0.75
72 Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin. Vaccine 1998 0.75
73 Effects of indomethacin on renal hemodynamic alterations caused by arterial and ureteral pressure changes in rabbits. Jpn Heart J 1979 0.75
74 [Acute nephrotic disorders--experimental acute ischemic renal failure]. Nihon Rinsho 1972 0.75
75 Effects of aminonucleoside on renal function. Jpn J Pharmacol 1972 0.75
76 Intra- and inter-nephron heterogeneity of gluconeogenesis in the rat: effects of chronic metabolic acidosis and potassium depletion. Pflugers Arch 1986 0.75
77 [Function of the kidney medulla and controlling factors: intervention by the cortical function]. Nihon Rinsho 1976 0.75
78 A young female case of polyarteritis nodosa strongly suspected by typical angiographic findings which improved rapidly after prednisolone and cyclophosphamide therapy. Intern Med 1992 0.75
79 [Renal circulation and control of water and electrolyte excretion]. Nihon Rinsho 1969 0.75
80 [Basis of kidney function tests. (1) Discrimination between cortical and medullary functions]. Nihon Jinzo Gakkai Shi 1976 0.75
81 Failure to abolish reactive hyperemia by indomethacin in denervated kidneys of rabbits. Am J Physiol 1977 0.75
82 [A case of asymptomatic pheochromocytoma]. Nihon Naika Gakkai Zasshi 1990 0.75
83 Mouse embryonic cells persistently infected with Japanese encephalitis virus. Kitasato Arch Exp Med 1975 0.75
84 [Electrolytes transport by the gallbladder and diuretics]. Nihon Rinsho 1984 0.75
85 [A case of obstructive jaundice due to inflammatory pseudotumor-like granuloma]. Nihon Naika Gakkai Zasshi 1990 0.75
86 Absence of renal circulatory autoregulation during perfusion with paraffin oil. Blood Vessels 1977 0.75
87 [Clq binding activity of monomeric IgG]. Arerugi 1982 0.75
88 [Urine concentrating and diluting ability in acute renal failure]. Nihon Rinsho 1991 0.75
89 Effects of atrial natriuretic peptide on glycerol induced acute renal failure in the rat. Jpn Heart J 1992 0.75
90 [Sodium transport in the gallbladder]. Nihon Rinsho 1982 0.75